The Newsroom
Item 1 of 3
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...
Item 2 of 3
AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes
Item 3 of 3
AdventHealth East Orlando First in Florida to Earn Advanced Foot & Ankle Surgery Certification from DNV
Recent Stories at AdventHealthMD
-
-
Aquadex Ultrafiltration Device Provides New Hemodialysis Option for Neonates Experiencing Renal Failure
-
AdventHealth Physician and Team Take Recently Developed Brain-Eating Amoeba Test to the Next Level to Accelerate Patient Diagnosis and Treatment
-
Eighth-Generation Physician Blends Science and Art with Her Eastern Heritage to Provide Whole-Person Care
-
AdventHealth for Women Orlando First in Florida Named Level IV Maternal Care Verified Facility by The Joint Commission
-
AdventHealth physicians call their mission trip to help children with facial defects a labor of love
-
New Research Shows Having an Inflammatory Side Effect During Monoclonal Antibody Treatments for Lung Cancer is Linked to Improved Survival Rates
-
AI-powered imaging device tested in real-time as part of AdventHealth prostate cancer research study
-
AdventHealth physicians explain Post-COVID Clinic model and first year research findings during American Hospital Association podcast